Japan / Product Areas / Vascular Access

Partnering with you to create successful vascular access strategies

Finding solutions to prevent vascular access device (VAD)-related complications requires strategic thinking and partnership among all levels.

Innovative Products

 Product Page link image

 

Consider the impact that VAD-related complications have on your healthcare facility

90 percent
hospital
pentalties

 

At Teleflex, we believe no one should suffer from the consequences of preventable vascular access-related complications. That’s why we’re partnering with healthcare facilities to offer a comprehensive, consultative approach to vascular access.

Customer Support - Japan

Teleflex Medical Japan, Ltd.
Shinjuku NS Bldg. 5F
2-4-1, Nishi-shinjuku
Tokyo, 163-0805 Japan
Fax: 81-3-6632-3631
Customer Service: 0570-055-160 (Domestic calls only)
Email Teleflex Medical Japan

References:

  1. Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of intravenous medication errors: implications for infusion pump technology. Qual Saf Health Care. 2005;14(2):80-86.
    doi: 10.1136/qshc.2004.011957.
  2. Medicare.gov. Hospital-Acquired Condition Reduction Program. https://www.medicare.gov/hospitalcompare/HAC-reduction-program.html. Accessed May 30, 2017.R. (2017, January 03). The Hospital Pay-for-Performance File How P4P may impact your hospital partners in 2017. Retrieved May 16, 2017, from https://www.advisory.com/research/health-care-industry-committee/members/resources/2014/p4p-impact-file.
  3. Centers for Medicare and Medicaid Services. Fiscal Year (FY) 2016 Results for the CMS Hospital-Acquired Conditions (HAC) Reduction Program. https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-sheets-items/2015-12-10-2.html. Accessed May 30, 2017.
Rx only

Teleflex, the Teleflex logo, Arrow, and EZ-IO are trademarks or registered trademarks of Teleflex Incorporated or its affiliates. MCI-2020-0469